chr14-104713565-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_022489.4(INF2):c.2999G>A(p.Ser1000Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000438 in 1,612,422 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_022489.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
INF2 | NM_022489.4 | c.2999G>A | p.Ser1000Asn | missense_variant | 20/23 | ENST00000392634.9 | |
INF2 | NM_001031714.4 | c.2999G>A | p.Ser1000Asn | missense_variant | 20/22 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
INF2 | ENST00000392634.9 | c.2999G>A | p.Ser1000Asn | missense_variant | 20/23 | 5 | NM_022489.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00194 AC: 295AN: 152176Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.000707 AC: 174AN: 246242Hom.: 1 AF XY: 0.000566 AC XY: 76AN XY: 134224
GnomAD4 exome AF: 0.000278 AC: 406AN: 1460126Hom.: 2 Cov.: 35 AF XY: 0.000246 AC XY: 179AN XY: 726308
GnomAD4 genome AF: 0.00197 AC: 300AN: 152296Hom.: 4 Cov.: 33 AF XY: 0.00211 AC XY: 157AN XY: 74464
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2020 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | - - |
Kidney disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Apr 03, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at